as on March 4, 2026 at 7:59 am IST
Day's Low
Day's High
1.10%
Downside
5.04%
Upside
52 Week's Low
52 Week's High
61.56%
Downside
20.37%
Upside
Check Karyopharm Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$175.9M
EPS (TTM)
-3.43
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.07
Industry PE ratio
-2.8652788104089217
PEG Ratio
-0.15
EBITDA
-90.4M
Revenue (TTM)
146.1M
Profit Margin
-134.21%
Return On Equity TTM
-891.05%
Track how Karyopharm Therapeutics Inc P/E has moved over time to understand its valuation trends.
Karyopharm Therapeutics Inc in the last 5 years
Lowest (-84.79x)
March 31, 2022
Industry (-2.87x)
March 4, 2026
Today (-1.07x)
March 4, 2026
Highest (-0.34x)
June 30, 2025
Today’s Price to Earnings Ratio: -1.07x
Compare market cap, revenue, PE, and other key metrics of Karyopharm Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $175.9M | -94.75% | -1.07 | -134.21% | |
| BUY | $123.5B | 128.24% | 31.75 | 32.94% | |
| BUY | $43.1B | 131.96% | 138.92 | 8.45% | |
| NA | $34.8B | NA | 593.13 | 5.37% | |
| BUY | $83.6B | 70.6% | 19.05 | 31.41% |
The Karyopharm Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Karyopharm Therapeutics Inc investment value today
Current value as on today
₹1,48,777
Returns
₹48,777
(+48.78%)
Returns from Karyopharm Therapeutics Inc Stock
₹43,328 (+43.33%)
Dollar Returns*
₹5,448 (+5.45%)
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Karyopharm Therapeutics Inc. Average target price of $15.33
Get share price movements and forecasts by analysts on Karyopharm Therapeutics Inc.
What analysts predicted
40.44%UPSIDE
Target Price
$15.33
Current Price
$9.13
Analyzed by
13 Analysts
Target
$15.33
Karyopharm Therapeutics Inc target price $15.33, a slight upside of 40.44% compared to current price of $9.13. According to 13 analysts rating.
Search interest for Karyopharm Therapeutics Inc Stock has increased by 48% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:48% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, KPTI stock has moved up by 44.9%
Best in 1 Year
![]()
In the last 1 year, KPTI has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 57.3% return, outperforming this stock by 137.9%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -33.12M → -102.19M (in $), with an average decrease of 208.5% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 44.04M → 34.07M (in $), with an average decrease of 22.6% per quarter
| Organisation | Karyopharm Therapeutics Inc |
| Headquarters | 85 Wells Avenue, Newton, MA, United States, 02459-3298 |
| Industry | Health Technology |
| CEO | Mr. Richard A. Paulson M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Kristin Abate | VP, Chief Accounting Officer & Assistant Treasurer |
Mr. James Accumanno J.D. | Chief Compliance Officer |
Ms. Lisa DiPaolo | Executive VP & Chief Human Resource Officer |
Ms. Lori A. Macomber CPA | EVP, CFO & Treasurer |
Mr. Brendan Twohig Strong | Senior Vice President of Investor Relations |
Mr. Michael J. Mano J.D. | Executive VP, Chief Legal Officer & Secretary |
Mr. Richard A. Paulson M.B.A. | President, CEO & Director |
Ms. Sohanya Cheng M.B.A. | Executive VP, Chief Commercial Officer & Head of Business Development |
Dr. Reshma Rangwala M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Research |
Dr. Sharon Shacham M.B.A., Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
Karyopharm Therapeutics Inc share price today is $9.13 as on at the close of the market. Karyopharm Therapeutics Inc share today touched a day high of $9.59 and a low of $9.03.
Karyopharm Therapeutics Inc share touched a 52 week high of $10.99 on and a 52 week low of $3.51 on . Karyopharm Therapeutics Inc stock price today i.e. is closed at $9.13,which is 16.92% down from its 52 week high and 160.11% up from its 52 week low.
Karyopharm Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Karyopharm Therapeutics Inc (KPTI) shares with as little as ₹92.038 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.38 in Karyopharm Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Karyopharm Therapeutics Inc share’s latest price of $9.13 as on March 4, 2026 at 2:29 am IST, you will get 1.0953 shares of Karyopharm Therapeutics Inc. Learn more about
fractional shares .
Karyopharm Therapeutics Inc stock has given -94.75% share price returns and 25.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?